Thursday - June 4, 2026
BMJ Group: GLP-1 Agonists Linked to Significantly Lower Long Term Risk of Knee Replacement
June 04, 2026
LONDON, England, June 4 (TNSjou) -- BMJ Group issued the following news release about Regional Anesthesia & Pain Medicine:

* * *

GLP-1 agonists linked to significantly lower long term risk of knee replacement

Greatest effect seen with sustained use and newer agents semaglutide and tirzepatide

-

GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with a significantly l . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products